Tumor recurrence in patients treated with direct-acting antivirals for hepatitis C following curative therapy: a cause for concern?

被引：0
|
作者：
Evren, Sevan [1 ]
Wong, David K. H. [1 ]
机构：
[1] Univ Toronto, Toronto Ctr Liver Dis, 200 Elizabeth St,EN9-228, Toronto, ON M5G 2C4, Canada
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
D O I：
10.21037/tcr.2016.08.06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S233 / S236
页数：4
相关论文
共 50 条
  • [41] Effects of Direct-Acting Antivirals on Insulin Resistance in Hepatitis C Patients
    Moon, Jooyoung
    Moon, Hanna
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 46 - 46
  • [42] Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis
    Fabrizi, Fabrizio
    Donato, Francesca M.
    Messa, Piergiorgio
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2017, 40 (10): : 531 - 541
  • [43] Retreatment of patients experiencing failure with Hepatitis C direct-acting antivirals
    Quinn, Nessa
    Bergin, Colm
    Bannan, Ciaran
    McKiernan, Susan
    Norris, Suzanne
    Farrell, Gillian
    Houlihan, Ciara
    Murray, Catherine
    Alvarado, Lewel
    Cullen, Noelle
    Finnerty, Linda
    Hunt, Suzanne
    Carr, Bernard
    Melanophy, Gail
    Coghlan, Miriam
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1211 - S1212
  • [44] Increased incidence or recurrence of hepatocellular carcinoma in hepatitis C virus cirrhotic patients treated with direct-acting antivirals: myth or fact?
    Maida, Marcello
    Cabibbo, Giuseppe
    Camma, Calogero
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (04) : 307 - 309
  • [45] Adherence to hepatocellular carcinoma screening in patients with hepatitis C cirrhosis treated with direct-acting antivirals against hepatitis C
    Suarez Zambrano, Elisaul
    Acosta-Lopez, Silvia
    Diaz Bethencourt, Dacil
    Soledad Garrido, Maria
    Suarez Darias, Ruth
    Perez Hernandez, Francisco Andres
    JOURNAL OF HEPATOLOGY, 2022, 77 : S931 - S931
  • [46] Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals
    Cabibbo, G.
    Cacciola, I.
    Cannavo, M. R.
    Madonia, S.
    Calvaruso, V.
    Petta, S.
    Di Stefano, M.
    Larocca, L.
    Prestileo, T.
    Tine, F.
    Digiacomo, A.
    Bertino, G.
    Giannitrapani, L.
    Benanti, F.
    Davi, A.
    Volpes, R.
    Guarneri, L.
    Averna, A.
    Scalisi, I.
    Iacobello, C.
    Mazzola, G.
    Cartabellotta, F.
    Portelli, V.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    Camma, C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S218 - S218
  • [47] Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antivirals
    Lopez-Couceiro, Laura
    Gomez-Dominguez, Elena
    Munoz-Gomez, Raquel
    Castellano-Tortajada, Gregorio
    Ibarrola-de-Andres, Carolina
    Fernandez-Vazquez, Inmaculada
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (02) : 159 - 160
  • [48] Interferon plus ribavirin therapy might cause substitutions in the target domain of direct-acting antivirals in patients with hepatitis C virus
    Wang, Y.
    Wei, L.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 69 : 235 - 235
  • [49] Long-Term Outcomes of Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals in Turkey
    Zerdali, Esra
    Bozkurt, Mediha
    Nakir, Inci Yilmaz
    Pehlivanoglu, Filiz
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2024, 30 (03): : 70 - 76
  • [50] Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
    Leal, Cassia
    Strogoff-de-Matos, Jorge
    Theodoro, Carmem
    Teixeira, Rosangela
    Perez, Renata
    Guarana, Thais
    Pinto, Paulo de Tarso
    Guimaraes, Tatiana
    Artimos, Solange
    VIRUSES-BASEL, 2023, 15 (01):
12345